Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was approved in 2020 as a treatment method for improving glycemic control in patients with Type 2 diabetes.
Semaglutide shows great promise for patients who are having difficulty losing weight.
How does Semaglutide work?
GLP-1 is a hormone produced in the small intestine that stimulates insulin secretion and inhibits glucagon secretion, thereby lowering blood sugar.
Complete the Form
One of our Semaglutide Therapy experts will reach out Right Away!
